세계의 고처리량 공정 개발(HTPD) 시장 예측(-2030년) : 유형별, 프로세스별, 기술별, 용도별, 최종사용자별, 지역별 세계 분석

According to Stratistics MRC, the Global High Throughput Process Development (HTPD) Market is accounted for $11.15 billion in 2024 and is expected to reach $20.52 billion by 2030 growing at a CAGR of 10.7% during the forecast period. High Throughput Process Development (HTPD) describes the use of automated systems, advanced instrumentation, and data analytics to rapidly test and optimize various processes in industries such as pharmaceuticals, biotechnology, chemicals, and materials science. It allows for the simultaneous testing of multiple conditions or variables, significantly speeding up research and development. HTPD accelerates drug discovery, chemical process optimization, and material development by efficiently screening large volumes of data, improving productivity, and reducing time-to-market for new products.

Market Dynamics:

Driver:

Increased demand for drug discovery and development

HTPD technologies allow pharmaceutical companies to screen large numbers of compounds quickly, optimizing the discovery of prospective drug candidates. This is in response to the growing need for faster and more efficient drug development to address complex diseases and health concerns. This expedited procedure lowers drug development expenses while significantly accelerating time to market. High-efficiency screenings and process optimization using HTPD systems are essential for improving drug development efforts as the pharmaceutical industry is under increasing pressure to provide novel therapies for a range of ailments.

Restraint:

High initial costs

For small to mid-sized businesses, the deployment of HTPD systems frequently necessitates a significant investment in robotics, sophisticated automation equipment, and specialist software, all of which might be prohibitively expensive. The entire cost is further increased by the infrastructure required for data management and integration with current systems. These hefty upfront expenses might make it difficult for many businesses to enter the market, particularly startups or those with tight resources. The initial price burden may hinder the adoption of HTPD, especially in businesses where cost-efficiency is a top priority or resources are limited, even though it promises long-term cost benefits by speeding up research and development.

Opportunity:

Rising complexity in chemical and material research

The need for effective and scalable testing techniques is growing as sectors including materials science, energy research, and chemicals become more complex. HTPD systems drastically cut down on development time by enabling researchers to rapidly test and tune several chemical formulations, reaction conditions, and material attributes at once. This capacity is essential for meeting the rising demand for sophisticated materials that need a great deal of accuracy and experimentation, such as polymers, catalysts, and nanomaterials. Accelerating innovation and meeting market expectations require the ability to manage this complexity through automated, high-throughput procedures.

Threat:

Risk of oversimplification

The rapid screening of huge amounts of chemicals and circumstances by HTPD technology speeds up process testing and optimization, but it also has the risk of missing important details in complicated systems. Because of its speed and automation, HTPD may miss rare or subtle variables that affect experiment results, resulting in conclusions that are either incomplete or too generalized. This oversimplification can lead to inaccurate or poor outcomes in highly specialized domains like materials science or drug discovery, which can eventually result in costly blunders and undermine the overall efficacy of the development process.

Covid-19 Impact:

The COVID-19 pandemic had a transformative impact on the High Throughput Process Development (HTPD) market. Initially, research and development activities faced significant disruptions, delaying projects and slowing progress. However, as the need for rapid vaccine and drug development intensified, HTPD methodologies gained prominence, facilitating accelerated screening and testing processes. This shift highlighted the importance of HTPD in enhancing diagnostic capabilities and drug discovery efficiency. Consequently, the post-pandemic phase is expected to witness sustained growth in the HTPD market, driven by advancements in technology and increased pharmaceutical R&D investments.

The laboratory instruments segment is expected to be the largest during the forecast period

The laboratory instruments segment is expected to account for the largest market share during the forecast period, due to the increasing demand for automation and efficiency in drug discovery. Advances in miniaturization and liquid-handling technologies enable the simultaneous testing of numerous samples, significantly enhancing throughput. Additionally, the integration of artificial intelligence and machine learning optimizes data analysis and experimental processes, leading to faster decision-making. The need for cost reduction and improved productivity further propels the adoption of sophisticated laboratory instruments, making them essential for modern pharmaceutical research and development initiatives.

The agriculture & food segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the agriculture & food segment is predicted to witness the highest growth rate. Advances in automation and digital technologies, such as IoT and AI, enable precise monitoring and management of agricultural processes, leading to improved crop yields and reduced resource waste. Additionally, rising consumer demands for quality and sustainability push agricultural producers to adopt high-throughput methodologies for faster development of innovative food products. This integration enhances the overall resilience and competitiveness of the agricultural sector in a rapidly evolving market.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share fuelled by the rapid growth of the pharmaceutical, biotechnology, and chemical industries. Countries like China, India, and Japan are increasing their investments in research and development, fueling the demand for efficient drug discovery and process optimization tools. Additionally, the region's expanding focus on personalized medicine, coupled with advancements in automation and AI technologies, is driving the adoption of HTPD systems to accelerate product development and enhance research capabilities across diverse sectors.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to the region's focus on accelerating drug discovery, improving process efficiency, and advancing personalized medicine is fueling demand for HTPD systems. Additionally, the presence of leading pharmaceutical companies, academic institutions, and contract research organizations (CROs) in North America fosters innovation and adoption of high-throughput technologies, making the region a key player in advancing HTPD solutions for faster, cost-effective development processes.

Key players in the market

Some of the key players in High Throughput Process Development (HTPD) market include Thermo Fisher Scientific Inc., Agilent Technologies, PerkinElmer Inc., Labcorp Drug Development, Biotage AB, Schrodinger, Inc., Waters Corporation, Eppendorf AG, Sartorius AG, GE Healthcare Life Sciences, Horiba Ltd., Hamilton Company, Qiagen N.V., Mettler-Toledo International Inc., and Tecan Group Ltd.

Key Developments:

In April 2024, PerkinElmer launched the LabChip GXII Touch platform, designed to provide high-throughput protein analysis and characterization. The platform helps speed up the drug discovery process by efficiently screening protein-based samples.

In February 2024, Agilent Technologies introduced an upgraded version of its 1290 Infinity II LC system, enhancing capabilities for high-throughput analysis in process development, particularly for pharmaceutical and biotechnology applications.

In October 2023, Thermo Fisher Scientific launched the KINGFISHER Flex instrument to further enhance automation in sample preparation for high-throughput process development, enabling faster and more efficient workflows in biotech and pharmaceutical applications.

Types Covered:

• Laboratory Instruments
• Services
• Automated Systems
• Software Solutions
• Consumables
• Other Types

Processes Covered:

• Upstream Process
• Downstream Process

Technologies Covered:

• Robotics & Automation
• Chromatography
• Ultraviolet-visible Spectroscopy
• Other Technologies

Applications Covered:

• Drug Discovery and Development
• Chemical Synthesis and Catalysis
• Materials Science
• Other Applications

End Users Covered:

• Pharmaceuticals & Biotechnology
• Agriculture & Food
• Academic Research & Government
• Contract Research Organizations (CROs)
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Technology Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global High Throughput Process Development (HTPD) Market, By Type

• 5.1 Introduction
• 5.2 Laboratory Instruments
  • 5.2.1 Automatic Integrated Workstation
  • 5.2.2 Automated Miniature Bioreactor System
• 5.3 Services
• 5.4 Automated Systems
• 5.5 Software Solutions
• 5.6 Consumables
  • 5.6.1 Miniature Prepacked Columns
  • 5.6.2 Micro-well Filter Plates
  • 5.6.3 Miniature Disposable Bioreactor
  • 5.6.4 Micropipettes and Pipette Tips
  • 5.6.5 Other Consumables
• 5.7 Other Types

6 Global High Throughput Process Development (HTPD) Market, By Process

• 6.1 Introduction
• 6.2 Upstream Process
• 6.3 Downstream Process

7 Global High Throughput Process Development (HTPD) Market, By Technology

• 7.1 Introduction
• 7.2 Robotics & Automation
• 7.3 Chromatography
• 7.4 Ultraviolet-visible Spectroscopy
• 7.5 Other Technologies

8 Global High Throughput Process Development (HTPD) Market, By Application

• 8.1 Introduction
• 8.2 Drug Discovery and Development
  • 8.2.1 Lead Identification and Optimization
  • 8.2.2 Formulation Development
  • 8.2.3 Biologics Manufacturing
• 8.3 Chemical Synthesis and Catalysis
• 8.4 Materials Science
• 8.5 Other Applications

9 Global High Throughput Process Development (HTPD) Market, By End User

• 9.1 Introduction
• 9.2 Pharmaceuticals & Biotechnology
• 9.3 Agriculture & Food
• 9.4 Academic Research & Government
• 9.5 Contract Research Organizations (CROs)
• 9.6 Other End Users

10 Global High Throughput Process Development (HTPD) Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Thermo Fisher Scientific Inc.
• 12.2 Agilent Technologies
• 12.3 PerkinElmer Inc.
• 12.4 Labcorp Drug Development
• 12.5 Biotage AB
• 12.6 Schrodinger, Inc.
• 12.7 Waters Corporation
• 12.8 Eppendorf AG
• 12.9 Sartorius AG
• 12.10 GE Healthcare Life Sciences
• 12.11 Horiba Ltd.
• 12.12 Hamilton Company
• 12.13 Qiagen N.V.
• 12.14 Mettler-Toledo International Inc.
• 12.15 Tecan Group Ltd.